New Study Supports Treatment of Childhood PH with PDE-5 Inhibitors
Infants, newborns and children with pulmonary hypertension (PH) can be safely and effectively treated with phosphodiesterase type 5 (PDE-5) inhibitors, according to a new study. The review study, “Pulmonary Hypertension Therapy and a Systematic Review of Efficacy and Safety of PDE-5 Inhibitors,” appeared in the journal Pediatrics. PDE-5 inhibitors such…